@article{Bai2019, 
author = {Jianjun Bai and Wenjing Zhou and Haixiang Wang and Bingqing Zhang and Jiuluan Lin and Xiancheng Song and Jia Li and Jing Ruan and Yiou Liu and Jie Shi and Jing He and Qian Feng},
title = {Value of stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation in treating drug-resistant focal epilepsy},
year = {2019},
journal = {Brain Science Advances},
volume = {5},
number = {3},
pages = {189-202},
keywords = {epilepsy, radiofrequency thermocoagulation, stereoelectroencephalography},
url = {https://www.sciopen.com/article/10.26599/BSA.2019.9050015},
doi = {10.26599/BSA.2019.9050015},
abstract = {Stereoelectroencephalography (SEEG) has been widely used in the presurgical evaluation of patients with medically intractable epilepsy. In the past, SEEG was commonly used as a method for mapping and localizing the epileptogenic zone (EZ). Since 2004, several studies have been conducted to examine the effectiveness of SEEG-guided radiofrequency thermocoagulation (RF-TC) in treating refractory epilepsy. However, the seizure-free and responder rates varied greatly across studies. We aimed to analyze the outcome of 56 patients who were treated with SEEG-guided RF-TC to evaluate the effectiveness of this treatment. SEEG-guided RF-TC can be considered as a treatment for refractory epilepsy. However, due to its limited efficacy, SEEG-guided RF-TC might be regarded as a temporary treatment performed under SEEG rather than a promising treatment for refractory epilepsy.}
}